Franklin Resources Inc. increased its position in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 43.2% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 6,685,987 shares of the medical equipment provider’s stock after buying an additional 2,017,857 shares during the quarter. Franklin Resources Inc.’s holdings in Zimmer Biomet were worth $601,204,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in ZBH. Hilton Head Capital Partners LLC acquired a new position in shares of Zimmer Biomet in the 4th quarter valued at $39,000. Capital International Sarl boosted its stake in Zimmer Biomet by 1.0% during the 4th quarter. Capital International Sarl now owns 38,511 shares of the medical equipment provider’s stock worth $3,463,000 after purchasing an additional 398 shares during the period. Capital International Ltd. CA grew its position in Zimmer Biomet by 14.2% during the 4th quarter. Capital International Ltd. CA now owns 24,782 shares of the medical equipment provider’s stock worth $2,228,000 after purchasing an additional 3,076 shares during the last quarter. Los Angeles Capital Management LLC acquired a new position in Zimmer Biomet in the fourth quarter valued at $87,000. Finally, Havemeyer Place LP purchased a new stake in shares of Zimmer Biomet in the fourth quarter valued at about $254,000. Hedge funds and other institutional investors own 88.89% of the company’s stock.
Insider Buying and Selling at Zimmer Biomet
In related news, SVP Lori Winkler sold 2,650 shares of the firm’s stock in a transaction dated Thursday, March 12th. The shares were sold at an average price of $94.66, for a total value of $250,849.00. Following the completion of the sale, the senior vice president owned 10,224 shares in the company, valued at $967,803.84. This trade represents a 20.58% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Sang Yi sold 5,000 shares of the company’s stock in a transaction dated Friday, May 29th. The stock was sold at an average price of $82.64, for a total transaction of $413,200.00. Following the transaction, the insider owned 27,251 shares in the company, valued at $2,252,022.64. The trade was a 15.50% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 1.28% of the stock is currently owned by insiders.
Analyst Ratings Changes
View Our Latest Stock Analysis on Zimmer Biomet
Zimmer Biomet Price Performance
Shares of NYSE:ZBH opened at $87.34 on Tuesday. Zimmer Biomet Holdings, Inc. has a 52 week low of $79.12 and a 52 week high of $108.29. The company has a 50-day moving average price of $87.65 and a 200 day moving average price of $90.48. The company has a market cap of $16.90 billion, a P/E ratio of 22.69, a PEG ratio of 2.02 and a beta of 0.47. The company has a quick ratio of 0.95, a current ratio of 1.73 and a debt-to-equity ratio of 0.50.
Zimmer Biomet (NYSE:ZBH – Get Free Report) last issued its earnings results on Tuesday, April 28th. The medical equipment provider reported $2.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.86 by $0.23. The business had revenue of $2.09 billion during the quarter, compared to the consensus estimate of $2.07 billion. Zimmer Biomet had a return on equity of 13.24% and a net margin of 9.05%.The company’s revenue for the quarter was up 9.3% on a year-over-year basis. During the same period in the prior year, the business posted $1.81 EPS. Zimmer Biomet has set its FY 2026 guidance at 8.400-8.550 EPS. Research analysts predict that Zimmer Biomet Holdings, Inc. will post 8.49 earnings per share for the current year.
Zimmer Biomet Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Thursday, June 25th will be issued a $0.24 dividend. The ex-dividend date of this dividend is Thursday, June 25th. This represents a $0.96 dividend on an annualized basis and a yield of 1.1%. Zimmer Biomet’s dividend payout ratio (DPR) is 24.94%.
About Zimmer Biomet
Zimmer Biomet (NYSE: ZBH) is a global medical device company focused on musculoskeletal healthcare. Headquartered in Warsaw, Indiana, the company designs, manufactures and markets a broad portfolio of products used to treat joint disorders, bone disorders and related conditions. Its customer base includes orthopaedic and dental surgeons, hospitals, ambulatory surgery centers and other healthcare providers that rely on implants, instruments and related services for reconstructive and restorative procedures.
The company’s product offerings span joint replacement systems for hips, knees and shoulders; trauma and extremities implants; spine and thoracic solutions; dental and craniomaxillofacial implants and prosthetics; and sports medicine devices.
Featured Stories
- Five stocks we like better than Zimmer Biomet
- 3 Stocks With Fresh Catalysts to Watch Before the July 4
- Amprius Insiders Are Selling: Should Investors Be Worried?
- A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus
- A Market Rotation Toward Quality Will Benefit These 3 ETFs
Want to see what other hedge funds are holding ZBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report).
Receive News & Ratings for Zimmer Biomet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet and related companies with MarketBeat.com's FREE daily email newsletter.
